WVE

2.5605.88%
CF

Christopher Francis

Chief Strategy Officer

Dr. Christopher Francis, also known as Chris, Ph.D., serves as Senior Vice President of Corporate Development and Head of Emerging Areas at Wave Life Sciences, Inc. since May 2017 until September 2026 and serves as Chief Strategy Officer since September 2026. Dr. Francis served as Senior Vice President of Corporate Development & Portfolio Management at WAVE Life Sciences Ltd since January 2017 to May 2017. Dr. Francis served as the Head of Business Development and Vice President at Wave Life Sciences, Inc. since April 2014 until December 2016. Prior to joining WAVE, Dr. Francis held senior operational, strategic and business development roles within GlaxoSmithKline Oncology from 2009 to 2014 and was a member of the team that established GlaxoSmithKline’s Rare Disease Unit. Before GlaxoSmithKline, Dr. Francis was a health care private equity associate at Two River LLC from 2008 to 2009. He began his career in pharmaceutical pricing and reimbursement consulting at IMS Health. Dr. Francis earned undergraduate and graduate degrees in biochemistry and molecular biology from the University of Melbourne and was a doctoral research associate at the University of Cambridge.

Positions